{"id":"W4407699006","doi":"10.1200/jco.2025.43.5_suppl.tps282","title":"ACCEL: [Ac-225]-PSMA-62 phase Ia/Ib/II clinical trial to characterize efficacy, safety, tolerability, and dosimetry in oligometastatic hormone-sensitive and metastatic castration-resistant prostate cancer.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"Eli Lilly and Company","keywords":"Medicine; Tolerability; Prostate cancer; Oncology; Internal medicine; Dosimetry; Clinical trial; Cancer; Adverse effect; Nuclear medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001140942,0.001809976,0.001184585,0.0004763653,0.0002728163,0.0009475801,0.0009104555,0.0009035328,0.005538906],"category_scores_gemma":[0.0004753826,0.0005047255,0.000700063,0.000540356,0.0007519163,0.0006163119,0.0003715533,0.00189743,0.001236923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001464164,"about_ca_system_score_gemma":0.001919556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002005113,"about_ca_topic_score_gemma":0.005894572,"domain_scores_codex":[0.9996741,0.0001125748,0.00001512619,0.00005524094,0.00005880053,0.00008421599],"domain_scores_gemma":[0.9996165,0.00002475361,0.00009729029,0.00003171058,0.00002449149,0.0002052136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5170964,0.07077504,0.00928882,0.001454453,0.001516244,0.0004700685,0.0003302157,0.005970952,0.1976145,0.001805409,0.01384842,0.1798296],"study_design_scores_gemma":[0.3929823,0.5541607,0.01509718,0.00007172493,0.000795859,0.0006922428,0.00006321197,0.003438196,0.02039596,0.0004545948,0.01179815,0.00004986449],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798233,0.002741709,0.001525225,0.0004332062,0.0001390187,0.005706606,0.003051304,0.0003419785,0.006237726],"genre_scores_gemma":[0.9770817,0.001986406,0.00355579,0.001026836,0.0001609372,0.004696435,0.004374532,0.00009209037,0.007025255],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005538906,"threshold_uncertainty_score":0.01852947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1915912869743374,"score_gpt":0.5557792121033651,"score_spread":0.3641879251290278,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}